This is a non-core endpoint: only basic statistics are computed.
Otitis media in diseases classified elsewhere
H8_OTIMEDINOTH
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
30 |
4. Check minimum number of eventsNone |
30 |
5. Include endpointsNone |
30 |
6. Filter based on genotype QC (FinnGen only) |
30 |
Control definitions (FinnGen only)
- Control exclude
- H8_MIDDLEMASTOID
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Otitis media in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Diseases of middle ear and mastoid
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 529 | 245 | 283 |
| Only index persons | 340 | 165 | 175 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 5.02 | 5.76 | 4.27 |
| Only index persons | 10.65 | 13.98 | 7.52 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 30 | 18 | 12 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 46.93 | 30.05 | 72.25 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
13
11.04
7.60
2.2
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
15
41
6.32
5.80
2.5
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
11
23
6.97
5.51
2.7
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
25
6.37
5.04
2.9
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
14
58
3.65
2.90
12.9
5.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
17
82
3.48
2.76
9.9
11.6
inr
1.0
1.3
—
5
35
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
11
6.50
2.68
1.0
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
9
27
4.30
2.66
2.3
2.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
9
28
4.14
2.57
1.1
1.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
25
165
4.08
2.51
6.8
4.6
—
21.6
—
0
5
(3002173) Hemoglobin [Mass/volume] in Arterial blood
6
15
4.71
2.16
8.3
13.8
g/l
124.8
119.9
—
6
15
(42870588) Differential panel, method unspecified - Blood
14
68
2.99
2.13
5.7
5.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
6
16
4.41
2.05
6.2
4.3
ng/l
101.2
91.0
—
6
16
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
17
94
2.87
2.03
17.9
6.3
mmol/l
1.2
1.2
0.12
17
89
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
11
5.21
2.02
2.0
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
11
5.21
2.02
1.4
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
11
5.21
2.02
1.4
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
13
63
2.88
1.96
17.8
5.8
—
—
—
0
0
(3002256) Pathology report gross observation
6
22
3.14
1.52
1.3
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
24
180
2.66
1.50
6.0
3.5
mm/h
21.2
11.1
0.87
24
168
(3012544) pH of Venous blood
8
34
2.83
1.42
14.8
3.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
17
108
2.32
1.37
6.1
4.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
62
2.22
1.13
1.9
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
17
115
2.10
1.10
15.2
5.8
umol/l
10.3
9.8
0.13
17
109
(46235355) HIV 1 and 2 tests - Meaningful Use set
13
80
2.10
1.07
2.0
2.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
12
73
2.07
1.01
4.3
3.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
12
73
2.07
1.01
1.3
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
8
44
2.11
0.96
3.1
2.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
45
2.06
0.94
1.5
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
9
52
2.04
0.87
2.0
4.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
11
68
1.98
0.86
4.0
2.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
14
95
1.89
0.84
5.5
3.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
5
23
2.40
0.80
16.2
2.3
umol/l
8.0
13.9
—
5
18
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
26
2.10
0.74
2.0
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
18
139
1.74
0.67
18.8
5.0
mmol/l
6.1
6.3
0.19
18
124
(3015736) pH of Urine
7
104
0.57
0.64
4.0
3.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
17
131
1.69
0.62
2.9
2.5
ug/l
78.0
79.2
0.02
17
118
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
7
99
0.62
0.50
4.0
4.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
8
56
1.58
0.48
3.8
3.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
5
33
1.62
0.44
1.0
2.5
g/l
2.7
2.4
—
5
27
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
68
1.46
0.43
2.2
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
15
0.00
0.42
0.0
1.6
—
—
—
0
0
(4010399)
0
16
0.00
0.42
0.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
5
74
0.61
0.42
2.2
4.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
17
0.00
0.42
0.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
18
0.00
0.41
0.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
10
74
1.53
0.38
1.5
2.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
11
84
1.49
0.37
4.8
3.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
20
174
1.45
0.33
4.3
4.0
pmol/l
14.4
14.4
0.00
20
153
(3044889) 12 lead EKG panel
17
144
1.42
0.32
4.1
3.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
16
136
1.38
0.29
8.6
2.6
u/l
45.1
34.4
0.48
16
129
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
22
198
1.42
0.27
3.7
3.7
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
11
0.00
0.22
0.0
5.2
—
1.3
—
0
11
(3038515) Glucose [Moles/volume] in Venous blood
0
11
0.00
0.22
0.0
5.2
—
6.9
—
0
11
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
10
0.00
0.22
0.0
4.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
10
0.00
0.22
0.0
4.2
—
3.9
—
0
10
(3035285) Chloride [Moles/volume] in Venous blood
0
10
0.00
0.22
0.0
4.2
—
107.6
—
0
10
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
10
0.00
0.22
0.0
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
13
0.00
0.21
0.0
6.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
66
1.29
0.19
3.5
2.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
69
1.22
0.18
3.4
2.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
43
1.19
0.11
2.6
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
6
53
1.16
0.10
2.0
1.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
2.0
—
1.6
—
0
6
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
50
1.00
0.00
1.2
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
62.0
—
0
8
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(1002224) Polysomnography panel
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
90.4
—
0
5
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_OTIMEDINOTH and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have H8_OTIMEDINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: H8_OTIMEDINOTH – Otitis media in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data